C. difficile Lab ID Reporting in NHSN Stanley Ostrawski RN, MS, MT(ASCP), CIC Infection Preventionist Consultant.

Slides:



Advertisements
Similar presentations
HAI Program Update Meredith Kanago, MSPH TDH Statewide CEDEP Meeting 30 April 2014.
Advertisements

Conducting Patient Safety Rounds with Staff. First Steps Set the stage –Unit and Hospital Leadership Support –Identify a “champion(s)” for each unit where.
Antimicrobial Stewardship: an HAI response activity in Connecticut Richard Melchreit, MD HAI Program Coordinator.
Measurement: the why and the what
Abstract Results continued Reference 1 McDonald LC, Coignard B, Dubberke E, et al. Recommendations for Surveillance of Clostridium difficile-Associated.
Introduction to the National Healthcare Safety Network (NHSN) Richard Rodriguez, MPH Connecticut Department of Public Health 4/9/2014 Thank you to CDC.
NHSN CASE STUDIES or… Russ’s title NHSN Jeopardy Allison Gibson Murad, MPH aka Allie “Trebek” NHSN Epidemiologist Surveillance for Healthcare-Associated.
James Marx, PhD, RN, CIC Broad Street Solutions October 2014.
TRAINING INFORMATION FOR QIA FACILITIES CDC can assist with PPM facility training!
There are no financial disclosures by any members of this project.
Calculating & Reporting Healthcare Statistics
An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
Accreditation Canada & ISMP Canada ISMP Community of Practice Medication Reconciliation October 15, 2008.
Results of the 2002 Emergency Pediatric Services and Equipment Supplement (EPSES) to the National Hospital Medical Care Survey (NHAMCS) Centers for Disease.
Growing a New Culture: Patient Safety Nancy Brumley Gessling, MSN, CIC Infection Prevention Copper Basin Medical Center.
Tennessee Center for Patient Safety Data Reporting.
Calculating & Reporting Healthcare Statistics
APIC Chapter 13 Journal Club April 15, 2015
Welcome to the GHA InfectionPrevention Power Hour December 18, 2014.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
Burton Garten Indiana State Department of Health.
Hospital Patient Safety Initiatives: Discharge Planning
Healthcare-Associated Infection (HAI) Prevention
NOSOCOMIAL INFECTION SURVEILLANCE METHODS Masud Yunesian, M.D., Epidemiologist.
MEDICAL RECORDS MANAGEMENT IN EYE CARE SERVICES 6.International classification of Disease & Procedures and the method of Indexing data.
Objectives After this session, the attendee should be able to:
Innovative Use of Electronic Hand Hygiene Monitoring to Control a Clostridium difficile cluster on a Hematopoietic Stem Cell Transplant Unit Natasha Robinson.
NHSN Data Submission Requirements 2013 Health Care Excel Cathie Pritchard LPN, RHIT Quality Data Reporting Technologist October 12, 2012.
Long Term Care CDI/MDRO Prevention Collaborative: Connecticut Program Update Richard Melchreit, MD HAI Program Coordinator.
Katherine Allen-Bridson, RN, BSN, MScPH, CIC, Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases.
Measurement: the why, the what, and the how Paula Griswold, MPH Executive Director Massachusetts Coalition for the Prevention of Medical Errors Nora McElroy,
CDI prevention: A call to action for nursing homes
NHSN Reporting for Laboratory-identified Clostridium difficile Infection (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) (Bacteremia) Presentation.
Public Health Surveillance
Indiana Healthcare Associated Infection Initiative Kickoff.
National Patient Safety Goals 2011
Background In 2009, the Centers for Disease Control and Prevention (CDC) introduced a module in the National Healthcare Safety Network (NHSN) allowing.
Using and Sharing Findings from Surveillance: Rates, Ratios Proportions, Data Display & OUTBREAKS Russ Olmsted, MPH, CIC
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
INTERACT COLLABORATIVE ORIENTATION SESSION NYSHFA/IPRO PARTNERSHIP Sara Butterfield, RN, BSN, CPHQ, CCM Christine Stegel, RN, MS, CPHQ NYSHFA/IPRO INTERACT.
GAPP Coaching Call C. difficile Prevention Working Session September 4, 2014 Jan Ratterree Lynne Hall Jean Allred.
Mary Andrus, BA, RN, CIC Division of Healthcare Quality Promotion
Background In July 2009, New York State (NYS) began using the National Healthcare Safety Network (NHSN) LabID Event module to report facility-wide Clostridium.
© 2009 CSTS: The Cardiovascular Surgical Translational Study Using the Centers for Disease Control and Prevention’s National Healthcare Safety Network.
Cohort 1A-C Coaching Call October 1, 2014 Facilitators: Lisa Carhuff Kathy McGowan Joyce Reid.
HIT FINAL EXAM REVIEW HI120.
AHRQ Safety Program for Long-term Care: HAIs/CAUTI Infection Prevention: Surveillance Essentials in Preventing Health Care-Associated Infections How to.
A RIDDLE WRAPPED IN A MYSTERY INSIDE AN ENIGMA: NHSN SURVEILLANCE DEFINITIONS MSIPC Fall 2015 Interactive Breakout Session Allison Murad, MPH Michigan.
National Reminders- Reminder Reports. Reminder Reports on Main Menu CFM Reminder Computed Finding Management... DEF Reminder Definition Management...
© 2008 Delmar Cengage Learning. Chapter 6 Length of Stay/Discharge Days.
Statistics Terminology. Statistics The mathematics of the collection, organization, summarization, and analysis of numerical data Involves both numbers.
Cohort Coaching Call “Cohort 9” October 15, 2014 Coaches: Tracy Rutland Jean Allred Jan Ratterree Lynne Hall.
Nimalie D. Stone, MD, MS Medical Epidemiologist for LTC GA LTC IC course Winter/Spring 2011 Infection surveillance as a tool for infection prevention in.
Hospital inpatient data James Hebblethwaite. Acknowledgements This presentation has been adapted from the original presentation provided by the following.
Risk Factors for Candida dubliniensis Bloodstream Infections Katherine Veltman, B.S., Peggy L. Carver, Pharm.D, FCCP The University of Michigan Health.
A ssociation of Public Health Observatories Hospital Activity data Roy Maxwell SWPHO & Bristol University Dr Richard Wilson Sandwell PCT.
TIPS FOR COMPLETING CRF’S October Antimicrobial Report Form 7  In iDataFax use the drop-down list to record the Antimicrobial Code. This will.
NHSN Reporting for Critical Access Hospitals
Impact of State Reporting Laws on Central Line– Associated Bloodstream Infection Rates in U.S. Adult Intensive Care Units Hangsheng Liu, Carolyn T. A.
Evaluation and management (E/M) Services
NH QCC Preview Teleconference
Michelle Charles MSN, RN Karen Vallejo MSN, RN, CIC
Engaging a Microsystem to Reduce 30-Day Readmissions on an Acute Care Unit Erin Johnson, MSN, RN, Sara Stetz, MSN, RN.
Robin Nettleton MSN RN St. Luke’s Elmore, Mountain Home
APIC Chapter 13 Journal Club
Intermountain APIC Chapter CIC training questions
Information for Action HCAI Surveillance Data: Laboratory data 15th July 2015 Mari Morgan WHAIP Surveillance.
C. Difficile Surveillance Quality Improvement Initiative Baystate Health System Anne Zawacki RN MPH CIC.
Intermountain APIC Chapter CIC training questions
CIC Practice Questions
Presentation transcript:

C. difficile Lab ID Reporting in NHSN Stanley Ostrawski RN, MS, MT(ASCP), CIC Infection Preventionist Consultant

Learning Objectives Review the structure and of the MDRO/CDAD Module within the Patient Safety Component of NHSN Describe the rationale for monitoring MDRO/CDAD Identify the methodology, protocols and definitions used in the data collection of MDRO/CDAD

Goal of CDAD (CDI) Module Monitoring C. difficile infection (CDI) will help to evaluate local trends and changes in the occurrence of these pathogens and related infections Provide a mechanism for facilities to report and analyze CDI data Note: The term CDI is replacing CDAD. Both terms represent the same illness and are used interchangeably.

Introduction C. difficile infection has increased in prevalence in U.S. hospitals over the last 30 years C. difficile has important implications for patient safety Options for treating patients with C. difficile are often extremely limited C. difficile infections are associated with increased lengths of stay, costs and mortality

CDAD Module CDI Infection Surveillance CDI LabID Event Reporting CDI Prevention Process Measures If you choose to monitor C. difficile, you must select at least one of these two reporting options! Adherence to Hand Hygiene Adherence to gown/glove use

Allows laboratory testing data to be used without clinical evaluation of the patient, allowing for a much less labor intensive method to track C. difficile.

Definitions Laboratory-Identified (LabID) Event: Any non-duplicate CDI-positive lab assay. CDI-positive Lab Assay: Positive lab assay for C. difficile toxin A and/or B, or toxin-producing organism detected from stool culture or other lab means Duplicate C. difficile-positive test: CDI-positive assay from same patient within 2 weeks of previous positive assay.

Required Minimum Reporting All non-duplicate CDI-positive lab assays per patient per month At least three consecutive months in a calendar year C. difficile testing performed routinely in lab, only on unformed (conforming to the shape of the container) stool samples JANFEBMARAPR MAYJUNJULAUG DEC SEP OCTNOV

Prior C. difficile positive in ≤ 2 weeks Duplicate Test Not a LabID Event Test on unformed stool sample Positive for C. difficile Not C. difficile Not a LabID Event No Yes

Reporting Method For CDI LabID Event reporting, use either: A – Facility-wide by location B -- Selected locations in the facility C – Facility-wide CDI LabID Event Reporting Settings: 1) Inpatient locations 2) Outpatient locations – where care provided to patients post-discharge OR prior to admission 31 No Newborn locations No outpatient dialysis centers

Forms for LabID Data Collection

Reporting Location Options – LabID Events Facility-wide by location: Report every location in the facility separately Patient days Admissions CDAD data Selected locations You choose the specific locations in your facility Patient days Admissions CDAD data Overall / Facility-wide Report all locations together Patient days Admissions CDAD data You can collect C. difficile Lab ID Event data:

Reporting Infections: Facility-wide by location Report separately from every location in the facility Medical + CDI LabID Reporting

Reporting Infections: Selected Locations Only Report separately for one or more specific locations of a facility Medical CDI LabID Reporting

Reporting Infections: Facility-wide Medical + CDI LabID Reporting Report data for entire facility together.

If you would like to monitor a specific location in addition to the entire facility, you may do so.

CDI LabID Event Form

Select “yes” if the LabID Event is being reported from an outpatient location where there are no admissions (e.g., emergency department, wound care, etc.) If the patient was an outpatient, Date Admitted to Facility and Date Admitted to Location are not required.

CDI LabID Event Form

If the LabID Event was reported from an outpatient location, leave this blank Enter the patient care area where the patient was assigned when the LabID specimen was collected Note: the “Transfer Rule” does not apply to LabID Events

CDI LabID Event Form Note: Because of existing business rules for edit checks in NHSN, the date of specimen collection must be the same date or later than the admission date.

CDI LabID Event Form Circle “Yes” if the patient has been an inpatient and discharged from your facility in the past 3 months

CDI LabID Event Form If the patient was discharged from your facility in the past 3 months, enter the most recent date of discharge.

CDI LabID Data Entry Screen Non-editable field. Will be auto-filled by the system only, depending on whether there is prior LabID Event entered for the same organism and same patient. If there is a previous LabID Event for this organism entered in NHSN in a prior month, the system will auto- populate with “Yes.

Denominator Data (LabID) If you are using Method A or B, complete a Denominator Record for each location

Denominator Data (LabID) If this is a single inpatient location, enter the total number of patient days for the month. If this is a single inpatient location, enter the total number of admissions for this location for the month

Denominator Collection (LabID) Check C.difficile as the organism that will be monitored in this location

FacWideIN Denominators This number would be the total number of patient days for the entire facility for the month minus any patient days for NICU or Well Baby Nurseries This number would be the total number of admissions for the entire facility for the month minus any admissions to NICUs or Well Baby Nurseries

Denominators – Outpatient Location

FacWideOUT Denominators If LabID C. difficile Events are being monitored at the FacWideOUT level, then Total Encounters minus any encounters for Well Baby Clinics must be entered here

CDI Metrics Note! The following categories and prevalence and incidence calculations are built into the analysis capabilities of NHSN.

Incidence vs. Prevalence Incidence Rate: measures the occurrences of new cases or events in a specific population during a given time period Prevalence Rate: measures the occurrence of existing (old and new) cases in a specific population during a given time period

Categories of CDI LabID Events Community Onset (CO): LabID Event collected as an outpatient or an inpatient ≤3 days after admission to the facility (i.e., days 1, 2, or 3) Community-Onset Healthcare Facility-Associated (CO-HCFA): CO LabID Event collected from a patient who was discharged from the facility ≤ 4 weeks prior to current date of stool specimen collection Healthcare Facility-Onset (HO): LabID Event collected >3 days after admission to the facility (i.e., on or after day 4)

CDI Prevalence Rates Admission Prevalence Rate By single locationBy facility # non-duplicate CDI LabID Events per patient per month identified ≤ 3 days after admission to the facility # patient admissions to the facility X 100 # non-duplicate CDI LabID Events per patient per month identified ≤ 3 days after admission to the specific location X 100 # patient admissions to the same location

Location Percent Admission Prevalence that is CO Note: the numerator in this formula does not include Admission Prevalent LabID Events that are CO-HFCA # Admission Prevalent LabID Events to a location that are CO Total # Admission Prevalent LabID Events X 100

Location Percent Admission Prevalence that is CO-HFCA # Admission Prevalent LabID Events to a location that are CO- HFCA Total # Admission Prevalent LabID Events X 100

Location Percent Admission Prevalence that is HO # Admission Prevalent LabID Events to a location that are HO Total # Admission Prevalent LabID Events X 100

Overall Patient Prevalence Rate Number of 1 st CDI LabID Events per patient per month for the location*, regardless of time spent in that location* Number of patient admissions to the location* * or facility

Outpatient Reporting X 100 # all non-duplicate CDI LabID Events per patient for the location # of patient encounters for the location # all non-duplicate CDI LabID Events per patient for the facility X 100 # of patient encounters for the location By specific location:Facility-wide (FacWideOUT)

CDI Incidence Rates Location CDI Incidence Rate # of Incident CDI LabID Events per month identified >3 days after admission to the location # of patient days for the location X 10,000

Facility CDI Healthcare Facility-Onset Incidence Rate # of all Incident HO CDI LabID Events per month in the facility # of patient days for the facility X 10,000 Note: this calculation is only accurate for Overall Facility-Wide Inpatient reporting

Facility CDI Combined Incidence Rate # of all Incident HO and CO-HCFA CDI LabID Events per month in the facility Number of patient days for the facility X 10,000 Note: this calculation is only accurate for Overall Facility-Wide Inpatient reporting

Metrics Summary – CDI LabID Events CDI Prevalence Rates Admission Prevalence Outpatient Prevalence Location % Admission Prevalence CO Location % Admission Prevalence CO-HCFA Location % Admission Prevalence HO Overall Patient Prevalence CDI Incidence Rates Location Incidence Facility HO Combined Incidence HO and CO-HCFA

Question I don’t have a strong statistics background and I’m not sure I have time to separate out the Healthcare Onset (HO) from the Community Onset (CO) MDROs. What should I do? No problem. The NHSN analysis tool automatically calculates the rates based on the information you provide using the reporting plan, event, and denominator information.